NCT02278133 2017-10-09Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway MutationsArray BioPharmaPhase 1/2 Completed20 enrolled